Neonatal Manifestations of Chronic Granulomatous Disease: MAS/HLH and Necrotizing Pneumonia as Unusual Phenotypes and Review of the Literature
- PMID: 34718934
- DOI: 10.1007/s10875-021-01159-4
Neonatal Manifestations of Chronic Granulomatous Disease: MAS/HLH and Necrotizing Pneumonia as Unusual Phenotypes and Review of the Literature
Abstract
Chronic granulomatous disease (CGD) is a rare inborn error of immunity (IEI), characterized by a deficient phagocyte killing due to the inability of NADPH oxidase to produce reactive oxygen species in the phagosome. Patients with CGD suffer from severe and recurrent infections and chronic inflammatory disorders. Onset of CGD has been rarely reported in neonates and only as single case reports or small case series. We report here the cases of three newborns from two different kindreds, presenting with novel infectious and inflammatory phenotypes associated with CGD. A girl with CYBA deficiency presented with necrotizing pneumonia, requiring a prolonged antibiotic treatment and resulting in fibrotic pulmonary changes. From the second kindred, the first of two brothers developed a fatal Burkholderia multivorans sepsis and died at 24 days of life. His younger brother had a diagnosis of CYBB deficiency and presented with Macrophage Activation Syndrome/Hemophagocytic Lympho-Histiocytosis (MAS/HLH) without any infection, that could be controlled with steroids. We further report the findings of a review of the literature and show that the spectrum of microorganisms causing infections in neonates with CGD is similar to that of older patients, but the clinical manifestations are more diverse, especially those related to the inflammatory syndromes. Our findings extend the spectrum of the clinical presentation of CGD to include unusual neonatal phenotypes. The recognition of the very early, potentially life-threatening manifestations of CGD is crucial for a prompt diagnosis, improvement of survival and reduction of the risk of long-term sequelae.
Keywords: CGD; CYBA; CYBB; HLH; MAS; Necrotizing pneumonia; Newborn.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
References
-
- Holland SM. Chronic granulomatous disease. Clin Rev Allergy Immunol [Internet]. 2010;38:3–10. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19504359
-
- Thomas DC, Charbonnier LM, Schejtman A, Aldhekri H, Coomber EL, Dufficy ER, et al. EROS/CYBC1 mutations: Decreased NADPH oxidase function and chronic granulomatous disease. J Allergy Clin Immunol. 2019;143:782-785.e1. - PubMed
-
- Prince BT, Thielen BK, Williams KW, Kellner ES, Arnold DE, Cosme-Blanco W, et al. Geographic Variability and Pathogen-Specific Considerations in the Diagnosis and Management of Chronic Granulomatous Disease. Pediatr Heal Med Ther [Internet]. 2020;11:257–68. Available from: http://www.ncbi.nlm.nih.gov/pubmed/32801991
-
- Yu H-H, Yang Y-H, Chiang B-L. Chronic Granulomatous Disease: a Comprehensive Review. Clin Rev Allergy Immunol. 2021;61(2):101–13. Available from: http://www.ncbi.nlm.nih.gov/pubmed/32524254
-
- Magnani A, Mahlaoui N. Managing Inflammatory Manifestations in Patients with Chronic Granulomatous Disease. Pediatr Drugs Springer International Publishing. 2016;18:335–45.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous